NEW YORK – Oxford Nanopore Technologies said on Monday that it has signed a distribution agreement for its MinIon nanopore sequencing devices and consumables with Avantor, a provider of technologies and services to the biopharma, healthcare, education and government, and applied materials industries.
Under the terms of the agreement, MinIon starter packs, flow cells, and Oxford Nanopore library preparation kits will be available to Avantor's customers in the US and Europe next month through the company's e-commerce platform. Other regions, including Canada, will be added in 2022. Avantor will also provide local support for MinIon. Customers will still be able to order these products, in addition to the firm's other devices and consumables, directly from Oxford Nanopore.
Financial and other details of the agreement were not disclosed.
"We see our collaboration with Avantor as a way of broadening access further, to more scientists in more global life science communities," Oxford Nanopore CEO Gordon Sanghera said in a statement.
Avantor is a Fortune 500 company based in Radnor, Pennsylvania.